Ensemble deep model for continuous estimation of Unified Parkinson's Disease Rating Scale III.


Journal

Biomedical engineering online
ISSN: 1475-925X
Titre abrégé: Biomed Eng Online
Pays: England
ID NLM: 101147518

Informations de publication

Date de publication:
31 Mar 2021
Historique:
received: 08 01 2021
accepted: 18 03 2021
entrez: 1 4 2021
pubmed: 2 4 2021
medline: 28 10 2021
Statut: epublish

Résumé

Unified Parkinson Disease Rating Scale-part III (UPDRS III) is part of the standard clinical examination performed to track the severity of Parkinson's disease (PD) motor complications. Wearable technologies could be used to reduce the need for on-site clinical examinations of people with Parkinson's disease (PwP) and provide a reliable and continuous estimation of the severity of PD at home. The reported estimation can be used to successfully adjust the dose and interval of PD medications. We developed a novel algorithm for unobtrusive and continuous UPDRS-III estimation at home using two wearable inertial sensors mounted on the wrist and ankle. We used the ensemble of three deep-learning models to detect UPDRS-III-related patterns from a combination of hand-crafted features, raw temporal signals, and their time-frequency representation. Specifically, we used a dual-channel, Long Short-Term Memory (LSTM) for hand-crafted features, 1D Convolutional Neural Network (CNN)-LSTM for raw signals, and 2D CNN-LSTM for time-frequency data. We utilized transfer learning from activity recognition data and proposed a two-stage training for the CNN-LSTM networks to cope with the limited amount of data. The algorithm was evaluated on gyroscope data from 24 PwP as they performed different daily living activities. The estimated UPDRS-III scores had a correlation of [Formula: see text] and a mean absolute error of 5.95 with the clinical examination scores without requiring the patients to perform any specific tasks. Our analysis demonstrates the potential of our algorithm for estimating PD severity scores unobtrusively at home. Such an algorithm could provide the required motor-complication measurements without unnecessary clinical visits and help the treating physician provide effective management of the disease.

Sections du résumé

BACKGROUND BACKGROUND
Unified Parkinson Disease Rating Scale-part III (UPDRS III) is part of the standard clinical examination performed to track the severity of Parkinson's disease (PD) motor complications. Wearable technologies could be used to reduce the need for on-site clinical examinations of people with Parkinson's disease (PwP) and provide a reliable and continuous estimation of the severity of PD at home. The reported estimation can be used to successfully adjust the dose and interval of PD medications.
METHODS METHODS
We developed a novel algorithm for unobtrusive and continuous UPDRS-III estimation at home using two wearable inertial sensors mounted on the wrist and ankle. We used the ensemble of three deep-learning models to detect UPDRS-III-related patterns from a combination of hand-crafted features, raw temporal signals, and their time-frequency representation. Specifically, we used a dual-channel, Long Short-Term Memory (LSTM) for hand-crafted features, 1D Convolutional Neural Network (CNN)-LSTM for raw signals, and 2D CNN-LSTM for time-frequency data. We utilized transfer learning from activity recognition data and proposed a two-stage training for the CNN-LSTM networks to cope with the limited amount of data.
RESULTS RESULTS
The algorithm was evaluated on gyroscope data from 24 PwP as they performed different daily living activities. The estimated UPDRS-III scores had a correlation of [Formula: see text] and a mean absolute error of 5.95 with the clinical examination scores without requiring the patients to perform any specific tasks.
CONCLUSION CONCLUSIONS
Our analysis demonstrates the potential of our algorithm for estimating PD severity scores unobtrusively at home. Such an algorithm could provide the required motor-complication measurements without unnecessary clinical visits and help the treating physician provide effective management of the disease.

Identifiants

pubmed: 33789666
doi: 10.1186/s12938-021-00872-w
pii: 10.1186/s12938-021-00872-w
pmc: PMC8010504
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32

Subventions

Organisme : NINDS NIH HHS
ID : R43 NS071882
Pays : United States
Organisme : NIA NIH HHS
ID : R44 AG044293
Pays : United States
Organisme : Directorate for Engineering
ID : 1936586
Organisme : Directorate for Computer and Information Science and Engineering
ID : 1942669

Références

JMIR Mhealth Uhealth. 2015 Mar 26;3(1):e29
pubmed: 25830687
J Neural Transm (Vienna). 2018 Oct;125(10):1417-1432
pubmed: 30145631
Ann Biomed Eng. 2020 Dec;48(12):2976-2987
pubmed: 33006005
Sensors (Basel). 2015 Sep 29;15(10):25055-71
pubmed: 26426020
Front Comput Neurosci. 2018 Sep 11;12:72
pubmed: 30254580
J Neurol Neurosurg Psychiatry. 2008 Apr;79(4):368-76
pubmed: 18344392
Mov Disord. 2008 Dec 15;23(16):2398-403
pubmed: 19025759
Mov Disord. 2008 Jul 15;23(9):1307-12
pubmed: 18464275
Med Eng Phys. 2019 May;67:33-43
pubmed: 30876817
IEEE J Biomed Health Inform. 2015 Nov;19(6):1777-93
pubmed: 26316236
Digit Biomark. 2020 Nov 26;4(Suppl 1):13-27
pubmed: 33442578
J Parkinsons Dis. 2013 Jan 1;3(3):399-407
pubmed: 23948993
IEEE Trans Biomed Eng. 2018 Jan;65(1):159-164
pubmed: 28459677
Comput Biol Med. 2017 May 1;84:114-123
pubmed: 28351715
IEEE Trans Inf Technol Biomed. 2009 Nov;13(6):864-73
pubmed: 19846382
J Parkinsons Dis. 2012;2(1):47-55
pubmed: 23939408
N Engl J Med. 2004 Dec 9;351(24):2498-508
pubmed: 15590952
Eur J Neurol. 2017 Dec;24(12):1532-1538
pubmed: 28940893
Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:1-4
pubmed: 30440318
Front Neurol. 2017 Sep 01;8:431
pubmed: 28919877
Parkinsons Dis. 2012;2012:719167
pubmed: 23133789
Mov Disord. 2019 May;34(5):657-663
pubmed: 30901495
Sci Rep. 2020 Apr 30;10(1):7377
pubmed: 32355166
JAMA Neurol. 2018 Jul 1;75(7):876-880
pubmed: 29582075
IEEE J Biomed Health Inform. 2015 May;19(3):803-14
pubmed: 25910263
Parkinsonism Relat Disord. 2014 Jan;20(1):37-40
pubmed: 24126021

Auteurs

Murtadha D Hssayeni (MD)

Department of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL, 33431, USA.

Joohi Jimenez-Shahed (J)

Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Michelle A Burack (MA)

Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA.

Behnaz Ghoraani (B)

Department of Computer and Electrical Engineering and Computer Science, Florida Atlantic University, Boca Raton, FL, 33431, USA. bghoraani@fau.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH